Serve as portable dry-eye and corneal endpoint device in P002 trial
Pleryon's P002 dry-eye candidate is entering a first-in-human trial; sponsors need consistent corneal and dry-eye measurements across sites. OCUTOP's portable topography and dry-eye assessment could be a trial instrument, generating revenue and clinical credibility for Ocuwell.
Evidence from the records
- “portable device for topography and dry eye assessment”
- “First-in-human trial of candidate P002 (dry eye) authorized by Health Canada (ITA)”
- If it works
- Device leasing and data services for the trial sites.
- First step
- Email Pleryon's clinical team a one-page on OCUTOP as a trial endpoint tool.
